Literature DB >> 23233703

Removing the unknown from the carcinoma of unknown primary.

Adil I Daud.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23233703     DOI： 10.1200/JCO.2012.45.7630

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

Review 1.  Progress in refining the clinical management of cancer of unknown primary in the molecular era.

Authors:  Elie Rassy; Nicholas Pavlidis
Journal:  Nat Rev Clin Oncol       Date:  2020-04-29       Impact factor: 66.675

2.  Survival outcome differences based on treatments used and knowledge of the primary tumour site for patients with cancer of unknown and known primary in Ontario.

Authors:  C S Kim; M B Hannouf; S Sarma; G B Rodrigues; P K Rogan; S M Mahmud; E Winquist; M Brackstone; G S Zaric
Journal:  Curr Oncol       Date:  2018-10-31       Impact factor: 3.677

3.  The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology.

Authors:  Cristina R Ferrone; David T Ting; Mohammed Shahid; Ioannis T Konstantinidis; Francesco Sabbatino; Lipika Goyal; Travis Rice-Stitt; Ayesha Mubeen; Kshitij Arora; Nabeel Bardeesey; John Miura; T Clark Gamblin; Andrew X Zhu; Darrell Borger; Keith D Lillemoe; Miguel N Rivera; Vikram Deshpande
Journal:  Ann Surg Oncol       Date:  2014-12-18       Impact factor: 5.344
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.